| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.985 | 0.001 | 0.995 | Xanthine oxidase inhibitor | 0.995 0.001 DBMET03278 0.986 0.001 DBMET03279 0.961 0.001 DBMET03280 0.985 0.001 DBMET03281 | DBMET03278 | |
| 0.792 | 0.002 | 0.792 | Uric acid excretion stimulant | 0.689 0.003 DBMET03278 0.745 0.002 DBMET03279 0.721 0.002 DBMET03280 0.753 0.002 DBMET03281 | ||
| 0.576 | 0.032 | 0.759 | Cyclophilin D inhibitor | 0.759 0.009 DBMET03278 0.611 0.025 DBMET03279 0.742 0.01 DBMET03280 0.586 0.03 DBMET03281 | DBMET03278 | |
| 0.517 | 0.002 | 0.517 | Urate transporter 1 inhibitor | 0.042 0.024 DBMET03278 0.299 0.003 DBMET03279 0.217 0.003 DBMET03280 0.516 0.002 DBMET03281 | ||
| 0.512 | 0.002 | 0.512 | Xanthine dehydrogenase inhibitor | 0.249 0.004 DBMET03278 0.376 0.003 DBMET03279 0.203 0.004 DBMET03280 0.366 0.003 DBMET03281 | ||
| 0.439 | 0.056 | 0.439 | Prostaglandin dehydrogenase inhibitor | 0.271 0.116 DBMET03279 0.266 0.119 DBMET03280 0.249 0.127 DBMET03281 | ||
| 0.412 | 0.07 | 0.412 | 15-Lipoxygenase inhibitor | 0.297 0.134 DBMET03279 0.294 0.136 DBMET03280 0.301 0.131 DBMET03281 | ||
| 0.396 | 0.078 | 0.396 | Histamine release inhibitor | 0.322 0.113 DBMET03278 0.352 0.099 DBMET03279 0.327 0.11 DBMET03280 0.37 0.091 DBMET03281 | ||
| 0.256 | 0.005 | 0.256 | Prostaglandin E2 antagonist | 0.05 0.035 DBMET03278 0.106 0.013 DBMET03279 0.137 0.01 DBMET03281 | ||
| 0.315 | 0.064 | 0.315 | Lipoxygenase inhibitor | 0.222 0.12 DBMET03279 0.282 0.08 DBMET03280 0.303 0.07 DBMET03281 | ||
| 0.229 | 0.004 | 0.268 | Peroxisome proliferator-activated receptor alpha agonist | 0.076 0.019 DBMET03278 0.141 0.007 DBMET03279 0.175 0.005 DBMET03280 0.268 0.003 DBMET03281 | DBMET03281 | |
| 0.255 | 0.031 | 0.299 | Insulin sensitizer | 0.19 0.084 DBMET03278 0.231 0.046 DBMET03279 0.244 0.038 DBMET03280 0.299 0.016 DBMET03281 | DBMET03281 | |
| 0.306 | 0.09 | 0.306 | Thyroid hormone antagonist | 0.237 0.132 DBMET03279 0.274 0.108 DBMET03281 | ||
| 0.296 | 0.091 | 0.438 | Vasodilator, coronary | 0.438 0.025 DBMET03278 0.207 0.176 DBMET03279 | DBMET03278 | |
| 0.293 | 0.092 | 0.293 | Thyroid hormone beta antagonist | 0.229 0.132 DBMET03279 0.208 0.147 DBMET03281 | ||
| 0.205 | 0.013 | 0.205 | Potassium channel (Ca-activated) activator | 0.139 0.032 DBMET03279 0.139 0.032 DBMET03280 0.139 0.032 DBMET03281 | ||
| 0.25 | 0.067 | 0.39 | Hypolipemic | 0.345 0.037 DBMET03278 0.28 0.055 DBMET03279 0.278 0.056 DBMET03280 0.39 0.027 DBMET03281 | DBMET03281 | |
| 0.183 | 0.003 | 0.228 | Peroxisome proliferator-activated receptor delta agonist | 0.125 0.004 DBMET03279 0.142 0.004 DBMET03280 0.228 0.003 DBMET03281 | DBMET03281 | |
| 0.192 | 0.013 | 0.192 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.073 DBMET03278 0.19 0.013 DBMET03279 0.167 0.018 DBMET03280 0.172 0.017 DBMET03281 | ||
| 0.24 | 0.066 | 0.24 | Neuropeptide Y2 antagonist | 0.185 0.15 DBMET03279 0.175 0.171 DBMET03281 | ||
| 0.179 | 0.019 | 0.319 | Mediator release inhibitor | 0.319 0.006 DBMET03278 0.128 0.041 DBMET03279 0.102 0.067 DBMET03280 0.135 0.036 DBMET03281 | DBMET03278 | |
| 0.211 | 0.051 | 0.325 | Amyloid beta precursor protein antagonist | 0.325 0.012 DBMET03279 0.194 0.062 DBMET03281 | DBMET03279 | |
| 0.167 | 0.012 | 0.174 | Keratolytic | 0.162 0.013 DBMET03279 0.174 0.011 DBMET03280 0.156 0.013 DBMET03281 | DBMET03280 | |
| 0.231 | 0.081 | 0.384 | Vasodilator | 0.384 0.026 DBMET03278 0.174 0.127 DBMET03280 | DBMET03278 | |
| 0.153 | 0.004 | 0.153 | Phosphodiesterase VII inhibitor | 0.084 0.022 DBMET03278 0.137 0.005 DBMET03279 0.136 0.005 DBMET03280 0.13 0.005 DBMET03281 | ||
| 0.146 | 0.004 | 0.213 | Sphingosine 1-phosphate receptor agonist | 0.213 0.003 DBMET03279 0.058 0.018 DBMET03280 0.149 0.004 DBMET03281 | DBMET03279 | |
| 0.149 | 0.01 | 0.149 | Prostaglandin antagonist | 0.054 0.036 DBMET03279 0.105 0.016 DBMET03281 | ||
| 0.151 | 0.013 | 0.187 | Peroxisome proliferator-activated receptor gamma agonist | 0.092 0.033 DBMET03278 0.14 0.015 DBMET03279 0.165 0.01 DBMET03280 0.187 0.008 DBMET03281 | DBMET03281 | |
| 0.224 | 0.093 | 0.532 | Hypoglycemic | 0.532 0.013 DBMET03278 0.219 0.096 DBMET03279 0.176 0.139 DBMET03280 0.247 0.078 DBMET03281 | DBMET03278 | |
| 0.133 | 0.004 | 0.222 | Sphingosine 1-phosphate receptor 1 agonist | 0.222 0.003 DBMET03279 0.062 0.012 DBMET03280 0.142 0.004 DBMET03281 | DBMET03279 | |
| 0.182 | 0.055 | 0.2 | Protein-tyrosine phosphatase inhibitor | 0.162 0.067 DBMET03278 0.158 0.071 DBMET03279 0.164 0.066 DBMET03280 0.2 0.047 DBMET03281 | DBMET03281 | |
| 0.133 | 0.01 | 0.138 | DNA gyrase inhibitor | 0.113 0.014 DBMET03279 0.138 0.01 DBMET03280 0.112 0.015 DBMET03281 | DBMET03280 | |
| 0.315 | 0.201 | 0.698 | Antiinflammatory | 0.698 0.031 DBMET03278 0.32 0.196 DBMET03279 0.48 0.096 DBMET03280 | DBMET03278 | |
| 0.251 | 0.147 | 0.435 | Immunosuppressant | 0.435 0.051 DBMET03278 0.292 0.12 DBMET03279 0.216 0.181 DBMET03280 0.239 0.157 DBMET03281 | DBMET03278 | |
| 0.147 | 0.044 | 0.147 | Protein kinase (CK2) alpha inhibitor | |||
| 0.109 | 0.009 | 0.109 | Dihydroorotate dehydrogenase inhibitor | 0.092 0.013 DBMET03279 0.065 0.025 DBMET03280 0.056 0.032 DBMET03281 | ||
| 0.234 | 0.137 | 0.489 | Cholesterol antagonist | 0.489 0.034 DBMET03278 | DBMET03278 | |
| 0.109 | 0.012 | 0.115 | Peroxisome proliferator-activated receptor gamma antagonist | 0.081 0.033 DBMET03279 0.094 0.019 DBMET03280 0.115 0.01 DBMET03281 | DBMET03281 | |
| 0.111 | 0.02 | 0.143 | Sphingosine 1-phosphate receptor 4 agonist | 0.103 0.024 DBMET03279 0.076 0.04 DBMET03280 0.143 0.01 DBMET03281 | DBMET03281 | |
| 0.18 | 0.09 | 0.18 | I kappa B kinase epsilon inhibitor | |||
| 0.128 | 0.058 | 0.144 | Protein-tyrosine phosphatase 1B inhibitor | 0.121 0.063 DBMET03278 0.108 0.071 DBMET03279 0.122 0.062 DBMET03280 0.144 0.048 DBMET03281 | DBMET03281 | |
| 0.086 | 0.018 | 0.086 | Prostaglandin F2 alpha antagonist | 0.059 0.049 DBMET03278 0.056 0.053 DBMET03279 0.064 0.039 DBMET03281 | ||
| 0.256 | 0.189 | 0.256 | DNA polymerase beta inhibitor | |||
| 0.073 | 0.009 | 0.073 | Retinoid X receptor agonist | 0.031 0.028 DBMET03279 0.059 0.014 DBMET03281 | ||
| 0.077 | 0.013 | 0.077 | Purinergic P2Y antagonist | 0.071 0.015 DBMET03279 0.045 0.031 DBMET03280 0.075 0.014 DBMET03281 | ||
| 0.072 | 0.01 | 0.072 | Phosphodiesterase 7A inhibitor | 0.068 0.012 DBMET03279 0.071 0.01 DBMET03280 0.065 0.015 DBMET03281 | ||
| 0.146 | 0.084 | 0.218 | Interferon gamma antagonist | 0.214 0.036 DBMET03278 0.134 0.103 DBMET03279 0.218 0.035 DBMET03280 0.136 0.099 DBMET03281 | DBMET03280 | |
| 0.077 | 0.017 | 0.077 | Heme oxygenase stimulant | 0.06 0.045 DBMET03278 0.074 0.02 DBMET03279 0.075 0.019 DBMET03280 0.072 0.022 DBMET03281 | ||
| 0.08 | 0.025 | 0.104 | Neuraminidase (influenza) inhibitor | 0.104 0.015 DBMET03278 0.076 0.028 DBMET03279 0.072 0.033 DBMET03280 0.067 0.04 DBMET03281 | DBMET03278 | |
| 0.068 | 0.018 | 0.097 | Sphingosine 1-phosphate receptor 5 agonist | 0.065 0.02 DBMET03279 0.059 0.027 DBMET03280 0.097 0.009 DBMET03281 | DBMET03281 | |
| 0.059 | 0.012 | 0.059 | Retinoid X alpha receptor agonist | 0.045 0.017 DBMET03281 | ||
| 0.097 | 0.05 | 0.097 | Calcium antagonist | |||
| 0.08 | 0.035 | 0.08 | Potassium channel large-conductance Ca-activated activator | 0.074 0.04 DBMET03279 0.077 0.037 DBMET03280 0.074 0.04 DBMET03281 | ||
| 0.26 | 0.215 | 0.26 | 5 Hydroxytryptamine release inhibitor | |||
| 0.099 | 0.057 | 0.099 | Phosphodiesterase 7B inhibitor | 0.096 0.062 DBMET03279 0.087 0.075 DBMET03280 | ||
| 0.095 | 0.054 | 0.099 | Potassium channel activator | 0.099 0.049 DBMET03280 | DBMET03280 | |
| 0.048 | 0.01 | 0.064 | Free fatty acid receptor 1 antagonist | 0.037 0.019 DBMET03279 0.033 0.025 DBMET03280 0.064 0.005 DBMET03281 | DBMET03281 | |
| 0.057 | 0.018 | 0.057 | Dihydroorotase inhibitor | |||
| 0.05 | 0.012 | 0.05 | Retinoid X receptor antagonist | 0.045 0.017 DBMET03281 | ||
| 0.188 | 0.151 | 0.188 | Transcription factor STAT3 inhibitor | |||
| 0.044 | 0.007 | 0.044 | Prostaglandin EP1 antagonist | 0.02 0.014 DBMET03281 | ||
| 0.177 | 0.143 | 0.23 | Cardiotonic | 0.23 0.096 DBMET03279 0.203 0.116 DBMET03280 | DBMET03279 | |
| 0.098 | 0.066 | 0.1 | 5-Lipoxygenase inhibitor | 0.1 0.064 DBMET03281 | DBMET03281 | |
| 0.097 | 0.066 | 0.097 | Carbonic anhydrase III inhibitor | |||
| 0.038 | 0.01 | 0.048 | Peroxisome proliferator-activated receptor alpha antagonist | 0.022 0.014 DBMET03280 0.048 0.008 DBMET03281 | DBMET03281 | |
| 0.121 | 0.093 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.229 | 0.202 | 0.229 | Transcription factor inhibitor | |||
| 0.082 | 0.058 | 0.082 | I kappa B kinase inhibitor | |||
| 0.215 | 0.192 | 0.574 | Antiobesity | 0.302 0.115 DBMET03278 0.216 0.191 DBMET03279 0.574 0.024 DBMET03280 | DBMET03280 | |
| 0.038 | 0.018 | 0.038 | Retinoid X alpha receptor antagonist | 0.034 0.025 DBMET03281 | ||
| 0.13 | 0.111 | 0.13 | Mcl-1 antagonist | |||
| 0.119 | 0.101 | 0.234 | Cell wall synthesis inhibitor | 0.234 0.019 DBMET03278 0.12 0.099 DBMET03279 0.153 0.063 DBMET03280 0.133 0.082 DBMET03281 | DBMET03278 | |
| 0.055 | 0.037 | 0.055 | Dihydroorotate oxidase inhibitor | |||
| 0.199 | 0.181 | 0.424 | Apoptosis antagonist | 0.424 0.032 DBMET03278 0.195 0.185 DBMET03281 | DBMET03278 | |
| 0.06 | 0.043 | 0.077 | Neuraminidase inhibitor | 0.077 0.028 DBMET03278 0.065 0.038 DBMET03279 | DBMET03278 | |
| 0.036 | 0.019 | 0.045 | Peroxisome proliferator-activated receptor delta antagonist | 0.032 0.025 DBMET03279 0.041 0.014 DBMET03280 0.045 0.011 DBMET03281 | DBMET03281 | |
| 0.07 | 0.055 | 0.07 | MAP3K7 inhibitor | |||
| 0.153 | 0.138 | 0.155 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.147 0.146 DBMET03280 0.155 0.136 DBMET03281 | DBMET03281 | |
| 0.023 | 0.009 | 0.023 | Retinoic acid beta receptor agonist | 0.022 0.01 DBMET03279 0.022 0.011 DBMET03280 0.022 0.01 DBMET03281 | ||
| 0.045 | 0.031 | 0.045 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.036 | 0.023 | 0.08 | Sphingosine 1-phosphate receptor 3 agonist | 0.08 0.008 DBMET03279 0.033 0.025 DBMET03281 | DBMET03279 | |
| 0.026 | 0.013 | 0.026 | Retinoid X gamma receptor agonist | 0.024 0.014 DBMET03281 | ||
| 0.041 | 0.029 | 0.041 | Cathepsin F inhibitor | |||
| 0.023 | 0.014 | 0.023 | Retinoic acid gamma receptor agonist | 0.021 0.019 DBMET03279 0.022 0.017 DBMET03281 | ||
| 0.031 | 0.022 | 0.031 | Prostaglandin agonist | 0.028 0.025 DBMET03281 | ||
| 0.107 | 0.099 | 0.116 | Bone formation stimulant | 0.116 0.089 DBMET03281 | DBMET03281 | |
| 0.023 | 0.017 | 0.023 | Prostaglandin E2 agonist | |||
| 0.217 | 0.214 | 0.217 | DNA directed DNA polymerase inhibitor | |||
| 0.028 | 0.025 | 0.032 | Prostaglandin D2 agonist | 0.029 0.024 DBMET03280 0.032 0.02 DBMET03281 | DBMET03281 | |
| 0.086 | 0.083 | 0.086 | Alpha 2d adrenoreceptor antagonist | |||
| 0.097 | 0.095 | 0.097 | Protein kinase (CK1) delta inhibitor | |||
| 0.057 | 0.055 | 0.1 | Leukotriene antagonist | 0.1 0.022 DBMET03281 | DBMET03281 | |
| 0.016 | 0.014 | 0.025 | Free fatty acid receptor 1 agonist | 0.019 0.011 DBMET03279 0.017 0.013 DBMET03280 0.025 0.008 DBMET03281 | DBMET03281 | |
| 0.081 | 0.083 | 0.096 | ABCA1 expression enhancer | 0.096 0.056 DBMET03279 0.089 0.067 DBMET03280 0.086 0.073 DBMET03281 | DBMET03279 | |
| 0.125 | 0.127 | 0.36 | Nitric oxide antagonist | 0.36 0.03 DBMET03278 | DBMET03278 | |
| 0.013 | 0.016 | 0.014 | Thyroid hormone alpha antagonist | 0.014 0.013 DBMET03281 | DBMET03281 | |
| 0.119 | 0.129 | 0.141 | Dual specificity phosphatase 3 inhibitor | 0.141 0.105 DBMET03281 | DBMET03281 | |
| 0.118 | 0.132 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.047 DBMET03278 | DBMET03278 | |
| 0.111 | 0.128 | 0.276 | Insulin secretagoues | 0.237 0.022 DBMET03278 0.276 0.015 DBMET03279 0.167 0.058 DBMET03281 | DBMET03279 | |
| 0.112 | 0.131 | 0.221 | NOS3 expression enhancer | 0.221 0.034 DBMET03278 | DBMET03278 | |
| 0.204 | 0.224 | 0.553 | Antibacterial | 0.553 0.028 DBMET03278 0.276 0.154 DBMET03281 | DBMET03278 | |
| 0.037 | 0.059 | 0.055 | Potassium channel (Inward rectifier) blocker | 0.055 0.028 DBMET03280 | DBMET03280 | |
| 0.018 | 0.041 | 0.087 | Sodium/glucose cotransporter 2 inhibitor | 0.087 0.004 DBMET03278 | DBMET03278 | |
| 0.109 | 0.132 | 0.12 | Phospholipase A2 inhibitor | 0.12 0.117 DBMET03281 | DBMET03281 | |
| 0.118 | 0.142 | 0.132 | Dual specificity phosphatase inhibitor | 0.132 0.117 DBMET03281 | DBMET03281 | |
| 0.11 | 0.142 | 0.121 | Thiol protease inhibitor | 0.121 0.115 DBMET03279 | DBMET03279 | |
| 0.018 | 0.055 | 0.07 | Sodium/glucose cotransporter inhibitor | 0.07 0.004 DBMET03278 | DBMET03278 | |
| 0.111 | 0.157 | 0.374 | Platelet adhesion inhibitor | 0.374 0.015 DBMET03278 0.134 0.125 DBMET03279 | DBMET03278 | |
| 0.048 | 0.096 | 0.065 | Potassium channel (ATP-sensitive) blocker | 0.065 0.05 DBMET03280 | DBMET03280 | |
| 0.052 | 0.104 | 0.062 | Glutamate (mGluR6) antagonist | 0.062 0.06 DBMET03281 | DBMET03281 | |
| 0.029 | 0.088 | 0.051 | Prostaglandin EP2 antagonist | 0.051 0.05 DBMET03281 | DBMET03281 | |
| 0.064 | 0.124 | 0.139 | Transcription factor NF kappa B stimulant | 0.139 0.018 DBMET03278 | DBMET03278 | |
| 0.042 | 0.11 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.034 DBMET03278 | DBMET03278 | |
| 0.071 | 0.146 | 0.1 | Multidrug resistance-associated protein 1 inhibitor | 0.1 0.078 DBMET03278 | DBMET03278 | |
| 0.115 | 0.194 | 0.144 | Succinate dehydrogenase inhibitor | 0.144 0.123 DBMET03281 | DBMET03281 | |
| 0.149 | 0.228 | 0.501 | Transcription factor NF kappa B inhibitor | 0.501 0.044 DBMET03278 | DBMET03278 | |
| 0.117 | 0.196 | 0.391 | Free radical scavenger | 0.391 0.03 DBMET03278 | DBMET03278 | |
| 0.028 | 0.115 | 0.259 | Selectin antagonist | 0.259 0.008 DBMET03278 | DBMET03278 | |
| 0.024 | 0.113 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.039 DBMET03278 | DBMET03278 | |
| 0.064 | 0.161 | 0.153 | Beta amyloid protein antagonist | 0.153 0.039 DBMET03278 | DBMET03278 | |
| 0.139 | 0.239 | 0.189 | Hypoxia-inducible factor 1 alpha inhibitor | 0.189 0.166 DBMET03278 | DBMET03278 | |
| 0.098 | 0.198 | 0.345 | Hepatoprotectant | 0.345 0.02 DBMET03278 | DBMET03278 | |
| 0.061 | 0.167 | 0.095 | MAP kinase kinase 1 inhibitor | 0.095 0.064 DBMET03279 | DBMET03279 | |
| 0.152 | 0.261 | 0.648 | Alpha-glucosidase inhibitor | 0.648 0.044 DBMET03278 | DBMET03278 | |
| 0.039 | 0.152 | 0.094 | Androgen antagonist | 0.094 0.052 DBMET03280 | DBMET03280 | |
| 0.097 | 0.224 | 0.219 | Non-steroidal antiinflammatory agent | 0.219 0.058 DBMET03278 | DBMET03278 | |
| 0.137 | 0.265 | 0.206 | Vasodilator, peripheral | 0.206 0.169 DBMET03278 | DBMET03278 | |
| 0.138 | 0.271 | 0.428 | Antithrombotic | 0.428 0.043 DBMET03278 | DBMET03278 | |
| 0.088 | 0.247 | 0.193 | Platelet antagonist | 0.193 0.106 DBMET03278 0.163 0.132 DBMET03279 | DBMET03278 | |
| 0.033 | 0.193 | 0.114 | Monophenol monooxygenase inhibitor | 0.114 0.066 DBMET03278 | DBMET03278 | |
| 0.036 | 0.229 | 0.104 | Expectorant | 0.104 0.064 DBMET03278 | DBMET03278 | |
| 0.055 | 0.251 | 0.109 | Cyclooxygenase 3 inhibitor | 0.109 0.091 DBMET03278 | DBMET03278 | |
| 0.036 | 0.232 | 0.054 | Lipocortins synthesis agonist | 0.054 0.053 DBMET03278 | DBMET03278 | |
| 0.043 | 0.253 | 0.135 | Beta glucuronidase inhibitor | 0.135 0.033 DBMET03278 | DBMET03278 | |
| 0.134 | 0.345 | 0.381 | Interleukin 2 agonist | 0.381 0.034 DBMET03278 | DBMET03278 | |
| 0.054 | 0.267 | 0.482 | Angiogenesis stimulant | 0.482 0.013 DBMET03278 | DBMET03278 | |
| 0.023 | 0.246 | 0.051 | Factor IXa inhibitor | 0.051 0.036 DBMET03278 | DBMET03278 | |
| 0.106 | 0.34 | 0.316 | Immunomodulator | 0.316 0.074 DBMET03278 | DBMET03278 | |
| 0.019 | 0.301 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.027 DBMET03278 | DBMET03278 | |
| 0.008 | 0.292 | 0.071 | Phosphodiesterase 2A inhibitor | 0.071 0.018 DBMET03280 | DBMET03280 | |
| 0.066 | 0.354 | 0.383 | Antioxidant | 0.383 0.038 DBMET03278 | DBMET03278 | |
| 0.019 | 0.314 | 0.049 | Heparanase inhibitor | 0.049 0.047 DBMET03278 | DBMET03278 | |
| 0.007 | 0.302 | 0.079 | Phosphodiesterase II inhibitor | 0.079 0.018 DBMET03280 | DBMET03280 | |
| 0.034 | 0.343 | 0.166 | Lipid peroxidase inhibitor | 0.166 0.058 DBMET03278 | DBMET03278 | |
| 0.007 | 0.344 | 0.078 | Antineoplastic antibiotic | 0.078 0.058 DBMET03278 | DBMET03278 | |
| 0.039 | 0.378 | 0.109 | Cell adhesion inhibitor | 0.109 0.075 DBMET03278 | DBMET03278 | |
| 0.052 | 0.403 | 0.329 | Tumour necrosis factor alpha release inhibitor | 0.329 0.044 DBMET03278 | DBMET03278 | |
| 0.083 | 0.441 | 0.326 | Toll-Like receptor 7 agonist | 0.326 0.095 DBMET03281 | DBMET03281 | |
| 0.038 | 0.404 | 0.33 | Immunostimulant | 0.33 0.07 DBMET03278 | DBMET03278 | |
| 0.012 | 0.385 | 0.063 | Protein 50S ribosomal subunit inhibitor | 0.063 0.028 DBMET03278 | DBMET03278 | |
| 0.078 | 0.453 | 0.32 | Toll-Like receptor agonist | 0.32 0.099 DBMET03281 | DBMET03281 | |
| 0.025 | 0.423 | 0.162 | Thrombolytic | 0.162 0.073 DBMET03278 | DBMET03278 | |
| 0.091 | 0.501 | 0.423 | Apoptosis agonist | 0.423 0.103 DBMET03278 | DBMET03278 | |
| 0.022 | 0.442 | 0.098 | AMP-activated protein kinase stimulant | 0.098 0.074 DBMET03278 | DBMET03278 | |
| 0.088 | 0.525 | 0.285 | Peptidyltransferase inhibitor | 0.285 0.031 DBMET03278 | DBMET03278 | |
| 0.011 | 0.523 | 0.049 | Antibiotic Aminoglycoside-like | 0.049 0.014 DBMET03278 | DBMET03278 | |
| 0.056 | 0.621 | 0.197 | Caspase 3 stimulant | 0.197 0.173 DBMET03278 | DBMET03278 | |
| 0.023 | 0.604 | 0.106 | Toll-Like receptor 4 antagonist | 0.106 0.06 DBMET03278 | DBMET03278 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |